Zcash miner Fortitude Mining Holdings has finalized a strategic agreement to merge with medical technology firm HeartSciences, establishing a pathway to public trading on the Nasdaq without the complexities of a traditional initial public offering. Announced on Tuesday, this all-stock transaction positions Fortitude's management team to assume full operational control of the combined entity, which will operate under the Fortitude brand name. The restructured company is slated to trade under the ticker symbol TUDE, pending necessary regulatory approvals, while existing HeartSciences shareholders will retain a minority ownership stake in the new organization. HeartSciences CEO Andrew Simpson articulated the strategic necessity of the move, noting that the deal liberates the enterprise from 'the constant cycle of raising capital' and presents the optimal trajectory for shareholder value. Although the merger unites two distinct sectors—digital asset mining and AI-enabled cardiac diagnostics—the transaction functions as a classic reverse merger, granting Fortitude immediate access to public capital markets through an existing listed vehicle. For HeartSciences, which has grappled with persistent capital requirements, the arrangement preserves shareholder exposure to a publicly traded entity while allowing its healthcare division to continue operations under Simpson's leadership. This structural approach mirrors recent precedents in the cryptocurrency sector, where firms like Bitcoin miner Core Scientific listed via a SPAC merger in 2022 and Cipher Mining achieved public status through a similar SPAC transaction. Market reaction to the announcement was immediate and volatile; shares of HeartSciences, currently trading under the ticker HSCS, surged as much as 91% on Tuesday, . Despite this market enthusiasm, HeartSciences has yet to generate meaningful commercial revenue and has recorded net losses for several consecutive years. Data compiled by Woofun AI indicates that the company generated minimal revenue in fiscal 2025 while its net loss expanded to $8.77 million from $6.61 million in the prior year. Nevertheless, HeartSciences advanced its product roadmap during fiscal 2025 by launching the MyoVista Insights software platform, a tool designed to modernize existing ECG management systems. In contrast, Fortitude has disclosed limited financial details as a privately held entity, though it reported scaling its annualized production to 157,000 Zcash (ZEC) as of May 31. At the time of publication, ZEC was trading at approximately $413 per token, CoinMarketCap data showed, valuing the asset with a market cap of $6.92 billion. Woofun AI analysis suggests that this merger structure allows Fortitude to capitalize on current asset valuations while mitigating the dilution risks often associated with traditional equity offerings in a volatile market environment.